StageZero Life Sciences Ltd.
SZLSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4 | $16 | $26 | $1 |
| - Cash | $0 | $2 | $7 | $0 |
| + Debt | $2 | $1 | $4 | $2 |
| Enterprise Value | $6 | $16 | $23 | $3 |
| Revenue | $4 | $5 | $4 | $0 |
| % Growth | -25.1% | 22.1% | 2,893.3% | – |
| Gross Profit | -$0 | $1 | $1 | -$1 |
| % Margin | -10.6% | 23.2% | 16.8% | -692.8% |
| EBITDA | -$10 | -$6 | -$6 | -$2 |
| % Margin | -270.6% | -112.2% | -150.7% | -1,756.2% |
| Net Income | -$11 | -$7 | -$7 | -$3 |
| % Margin | -300.8% | -147.7% | -165.3% | -2,510.2% |
| EPS Diluted | -0.11 | -0.1 | -0.15 | -0.16 |
| % Growth | -10% | 33.3% | 6.3% | – |
| Operating Cash Flow | -$4 | -$9 | -$3 | -$5 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$9 | -$3 | -$5 |